Demant A/S (DEMANT.CO) Stock Price
Demant A/S Price
Revenue has compounded at 8.3% per year over the past 19 years to 23.08 B DKK. Earnings per share have grown at 5.1% per year over the last 19 years. Demant A/S's net margin stands at 6.7%, down from 13.7% several years earlier. Analysts set a median price target of 265.20 DKK, implying 17.5% below the current price. Of 26 analysts, 15 rate the stock a buy — an overall Buy consensus.
Demant A/S stock price
Demant A/S business model & stock analysis
Frequently asked questions about Demant A/S
The business model of Demant A/S is focused on providing innovative hearing healthcare solutions. Demant A/S operates through its four business segments - Hearing Devices, Diagnostic Instruments, Hearing Implants, and Personal Communication. With a strong emphasis on research and development, the company offers a wide range of hearing aids, wireless communication devices, and diagnostic instruments for better hearing and communication. Demant A/S aims to improve the quality of life for individuals with hearing loss by constantly striving to develop advanced and personalized solutions.
Demant A/S is primarily active in the healthcare industry, specifically focusing on hearing healthcare solutions. The company specializes in the development, manufacturing, and distribution of hearing aids, audiological diagnostics, and other hearing healthcare products. Demant A/S operates through various subsidiaries and brands, offering comprehensive solutions for individuals with hearing loss and professionals in the audiology field. With a strong presence in the global market, Demant A/S continues to innovate and provide cutting-edge technologies and services to improve the quality of life for those with hearing impairments.
The main competitors of Demant A/S in the market are Sonova Holding AG, William Demant Holding A/S, and GN Store Nord A/S.
Demant A/S, a leading global provider of hearing healthcare solutions, has a rich history and background. Established in 1904 in Denmark, Demant has consistently focused on innovation and advanced technology to improve the quality of life for people with hearing difficulties. With a strong emphasis on research and development, the company has been a pioneer in hearing aid technology, cochlear implants, and diagnostic equipment. Demant A/S operates through various well-known brands, including Oticon, Bernafon, and Sonic, offering a wide range of hearing solutions worldwide. With its commitment to excellence and customer satisfaction, Demant A/S continues to make significant contributions to the field of hearing healthcare.
Demant A/S, a renowned company in the stock market, has accomplished several significant milestones throughout its history. With a strong commitment to innovation and excellence, Demant A/S has achieved remarkable feats. Some notable milestones include the successful development and introduction of revolutionary hearing aid technologies, strategic acquisitions and partnerships, expanding its global presence, and consistently delivering exceptional financial performance. Demant A/S's dedication to providing cutting-edge solutions and improving the lives of individuals with hearing loss has solidified its position as a leader in the industry. With its continual progress and forward-thinking strategies, Demant A/S remains a force to reckon with in the stock market.
Demant A/S is primarily present in several countries and regions around the world. The company has a strong presence in North America, Europe, and the Asia Pacific region. In North America, Demant A/S operates through its subsidiary, Demant Inc., and has a significant market share in the hearing healthcare industry. In Europe, the company has a broad presence with operations in various countries including Denmark, Germany, and the United Kingdom. Additionally, Demant A/S has a growing presence in the Asia Pacific region, particularly in China and Australia. With its global footprint, Demant A/S serves customers and delivers innovative hearing solutions in multiple countries and regions.
Demant A/S represents a commitment to better hearing healthcare and enhanced communication. As a global leader in hearing healthcare solutions, Demant A/S places emphasis on innovation, research, and collaboration. The company strives to empower individuals with hearing loss through groundbreaking technology and personalized services. With a strong corporate philosophy focusing on transparency, integrity, and customer-centricity, Demant A/S aims to improve the quality of life for people with hearing challenges. With its comprehensive range of hearing devices, solutions, and support, Demant A/S is dedicated to enabling individuals to stay connected and engaged in their everyday lives.
Analysts currently set an average price target of 268.83 DKK for the Demant A/S stock (median: 265.20 DKK), implying -16.4 % versus the latest price. The consensus is based on 26 analyst ratings.
26 analysts currently rate the Demant A/S stock: 15 recommend buying, 10 holding and 1 selling. For 2026, analysts expect Demant A/S to generate revenue of 26.34 B DKK and earnings per share of 13.97 DKK.
Converted at the current exchange rate, the Demant A/S share trades at 43.00 EUR (321.40 DKK).
The Demant A/S share (DEMANT.CO) is listed on 9 stock exchanges, including: London (0RGT.L), SIX (Zürich) (WDH.SW), Frankfurt (WDH1.F), München (WDH1.MU), Düsseldorf (WDH1.DU), Wien (DEMA.VI), Kopenhagen (DEMANT.CO).
The company Demant A/S is a Danish company specializing in the field of hearing aids and hearing technology. It has been a leading company in the audiology industry for many years and offers a wide range of products, from hearing aids to wireless communication systems. The core business of Demant A/S is the production of hearing aids. The company offers various models of hearing aids tailored to the individual needs of customers. Emphasis is placed on achieving the most natural sound quality possible in order to maximize comfort for the wearer. However, Demant A/S is not solely focused on hearing aids. The company also offers wireless communication systems and accessories designed to make everyday life easier for people with hearing problems. For example, there are various wireless products that allow people with hearing problems to enjoy high-quality sound while watching TV, listening to music, or making phone calls. Another important aspect of Demant A/S is otoplastics. These are individually customized hearing aids, often referred to as "custom-made," which are made by hearing aid acousticians. Otoplastics are frequently used in individuals with specific requirements for their hearing aids due to anatomical peculiarities or hearing loss. In recent years, Demant A/S has also focused on the field of digital health. This includes digital health solutions tailored to the individual needs of patients and customers, including apps that enable people with hearing problems to measure and monitor their hearing loss and adjust their hearing aids individually. Overall, Demant A/S has a broad business model that encompasses all areas of the audiology industry. The company offers a comprehensive portfolio of products and services that enable people with hearing problems to improve their quality of life. The focus is on providing individualized advice and support to customers in order to create the best possible customer loyalty. Due to the aging population and the increasing prevalence of hearing problems, experts predict that the market for hearing aids will continue to grow in the coming years. Demant A/S positions itself as a promising player in this market with its wide range of products and extensive industry experience.
The expected revenue of Demant A/S is 26.34 B DKK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Demant A/S is 2.94 B DKK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Demant A/S is currently 23.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Demant A/S stock.
The price-to-sales ratio (P/S) of Demant A/S is currently 2.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Demant A/S stock.
The Eulerpool Quality Score for Demant A/S is 7/10.
The ISIN of Demant A/S is DK0060738599. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Demant A/S is A2AKB9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Demant A/S is DEMANT.CO. The ticker symbol is used to trade Demant A/S shares on the stock exchange.
Demant A/S stock
All fundamentals and in-depth analysis of Demant A/S
Our stock analysis for Demant A/S stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Demant A/S. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.